Physician profile
Alec J Chaleff
NPI 1598298895
$2,445.39
in general payments reported to CMS, 2019-2025
19 companies · $683 in 2025
The $683 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.07 · 2021: $135 · 2022: $405 · 2023: $832 · 2024: $368 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,848 · Education: $35.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,847.91 |
| Education | $35.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $547.60 | 2022-2025 | Miebo, Vyzulta |
| Alcon Vision LLC | $440.95 | 2019-2025 | Hydrus Microstent, Clareon Panoptix Pro, Rocklatan |
| Abbvie INC. | $361.85 | 2022-2025 | Durysta |
| Abbott Laboratories | $250.22 | 2021-2024 | Amplatzer Amulet, Aveir, Confirm Rx |
| Harrow Eye, LLC | $213.21 | 2024-2025 | Ilevro, Vevye |
| Johnson & Johnson Surgical Vision, INC. | $189.73 | 2022-2025 | Tecnis Iol |
| Boston Scientific Corporation | $98.01 | 2024-2025 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $48.36 | 2021-2022 | |
| Rxsight INC | $41.89 | 2022 | |
| Rayner Intraocular Lenses Limited | $37.35 | 2022 | |
| Sun Pharmaceutical Industries INC. | $31.08 | 2025 | |
| Santen INC. | $27.71 | 2023 | Verkazia |
| Novo Nordisk INC | $27.09 | 2025 | Ozempic |
| Dompe US, INC. | $25.33 | 2025 | Oxervate |
| Biotissue Holdings INC. | $24.49 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $24.29 | 2025 | Nexletol |
| Astellas Pharma US INC | $19.94 | 2024 | Izervay |
| Merck Sharp & Dohme LLC | $19.25 | 2024 | Verquvo |
| Thea Pharma INC. | $17.04 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alec Chaleff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.